PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN |
|---|---|---|---|---|
| Emergent Biosolutions, Inc. | EBS | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.31 | -0.63% | 48.69 | 49.8999 | 48.25 | 48.89 | 49 | 15:55:37 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,228 | 596,644 | $ 49.0215 | $ 29.25M | 432.92k | 46.93 - 73.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:55:40 | 100 | $48.69 | USD |
Emergent Biosolutions, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.49B | 51.2M | $ 62.7M | 1.25 | 40.50 | 42.07M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 34.1k | 129.20% |
Emergent Biosolutions, Inc. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/22/2019 | 12:57 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) |
| 3/21/2019 | 16:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/21/2019 | 16:13 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 3/20/2019 | 12:08 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) |
| 3/19/2019 | 06:30 | GlobeNewswire Inc. | Emergent BioSolutions Initiates Phase 3 Clinical Study to.. |
| 3/13/2019 | 17:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/04/2019 | 18:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EBS Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 50.59 | 50.85 | 47.59 | 49.3253 | 447k | 1M | 831k | -1.9 | -3.76% |
| 1 Month | 65.98 | 67.45 | 47.59 | 54.6948 | 391k | 1M | 697k | -17.29 | -26.20% |
| 3 Months | 58.63 | 67.45 | 47.59 | 58.0967 | 160k | 1M | 444k | -9.94 | -16.95% |
| 6 Months | 65.88 | 73.89 | 47.59 | 60.9908 | 122k | 1M | 370k | -17.19 | -26.09% |
| 1 Year | 53.59 | 73.89 | 46.93 | 58.5373 | 108k | 1M | 307k | -4.9 | -9.14% |
| 3 Years | 33.92 | 73.89 | 24.47 | 41.8932 | 69k | 10M | 354k | 14.77 | 43.54% |
| 5 Years | 25.08 | 73.89 | 19.31 | 37.6831 | 69k | 10M | 322k | 23.61 | 94.14% |
Emergent Biosolutions, Inc. Description
| Emergent BioSolutions, Inc. is a biopharmaceutical company, which is focused on the development, manufacture and commercialization of vaccine and immune-related therapeutic that assist the body’s immune system to prevent or treat disease. |
